Organic Process Development » Discussions

Ph.D

Bookmark and Share




CTI BioPharma receives Israeli approval for aggressive B-cell non-Hodgkin’s lymphoma therapy

Jul 22, 2014 | 09:07

No comments  

You should sign in or sign up for comment this post